Red Arrow Therapeutics has closed a $4.5M Seed Extension round, raising from four, top-tier institutional investors in Japan: Beyond Next Ventures, The University of Tokyo Edge Capital Partners, Keio Innovation Initiative, and OSAKA University Venture Capital.Red Arrow Therapeutics is a biotech startup founded in 2021 and headquartered in US, developing an innovative drug delivery system with nanotechnology..

Red Arrow Therapeutics完成了一轮450万美元的种子推广，资金来自日本四家顶级机构投资者：Beyond Next Ventures、东京大学边缘资本合作伙伴、庆应义塾创新倡议和大阪大学风险投资。Red Arrow Therapeutics是一家成立于2021年的生物技术初创公司，总部位于美国，利用纳米技术开发创新的药物输送系统。